Mometasone Furoate in Preventing Radiation Dermatitis in Patients Undergoing Radiation Therapy to the Breast or Chest Wall for Invasive Breast Cancer or Ductal Carcinoma in Situ
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer|Dermatologic Complications|Radiation Toxicity|Skin Reactions Secondary to Radiation Therapy
Interventions: DRUG: mometasone furoate|OTHER: placebo
Sponsor: North Central Cancer Treatment Group
Collaborators: National Cancer Institute (NCI)